cbdMD Inc
Research cbdMD Inc (YCBD) on Bullrun: market cap USD 5.44M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerYCBD
- ExchangeNYSE MKT
- CountryUnited States
- SectorHealthcare
- IndustryDrug Manufacturers-Specialty & Generic
- CurrencyUSD
- Market capUSD 5.44M
- Financial periodQ1 2026
- RevenueUSD 5.64M
- Net income-USD 797.98K
- Free cash flow-USD 728.25K
- Gross margin57.7%
Valuation Snapshot
latest market cap is USD 5.44M.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | USD 19.19M | -USD 2.04M | -USD 1.64M | 62.4% | -1.09 | USD 2.26M | USD 593.03K | USD 7.23M |
| FY2024 | USD 19.48M | -USD 3.70M | -USD 542.81K | 61.6% | -14.29 | USD 2.45M | USD 1.63M | USD 1.96M |
| FY2023 | USD 24.16M | -USD 22.94M | -USD 4.60M | 62.0% | -13.32 | USD 1.80M | USD 9 | USD 9.03M |
| FY2022 | USD 35.40M | -USD 70.08M | -USD 15.66M | 63.1% | -55.8 | USD 6.72M | USD 125.49K | USD 31.42M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-25 | USD 5.44M | n/a | n/a | n/a |
| 2025 | 2025-12-31 | USD 13.60M | n/a | n/a | n/a |
| 2024 | 2024-12-31 | USD 2.08M | n/a | n/a | n/a |
| 2023 | 2023-12-29 | USD 3.08M | n/a | n/a | n/a |
| 2022 | 2022-12-30 | USD 13.78M | n/a | n/a | n/a |
| 2021 | 2021-12-31 | USD 62.95M | n/a | n/a | n/a |
About cbdMD Inc
cbdMD, Inc. produces and distributes various cannabidiol (CBD) products in the United States and internationally. The company owns and operates various consumer hemp-based CBD brands. Its cbdMD brand products include oils, gummies, capsules, soft-gels, topicals, functional formulations, and hemp-derived compliant Delta-9 THC products. It also provides products for dogs and cats, including tinctures, chews, and topicals under the Paw CBD brand name;
Related stock research
Other Healthcare stocks
Frequently asked questions
What is cbdMD Inc's market cap?
cbdMD Inc's market capitalization is USD 5.44M.
What does cbdMD Inc do?
cbdMD, Inc. produces and distributes various cannabidiol (CBD) products in the United States and internationally. The company owns and operates various consumer hemp-based CBD brands. Its cbdMD brand products include oils, gummies, capsules, soft-gels, topicals, functional formulations, and hemp-derived compliant Delta-9 THC products. It also provides products for dogs and cats, including tinctures, chews, and topicals under the Paw CBD brand name; non-cannabinoid functional ingredients, such as functional mushrooms under the ATRx brand; and hemp-derived solutions under the Herbal Oasis brand.